Tivic Health Systems VBIO
Tivic Health Systems Q2 FY24: revenue $140K; diluted EPS −$5.44
- Form
- 10-Q
- Filed
- Period
- Importance
- Notable
- Accession
- 0000950170-24-097056
- Document
- 10-Q
Key figures from this report
These are the numbers Tivic Health Systems reported for Q2 FY24, the quarter ended Jun 30, 2024, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.
- Revenue$140KNo year-earlier figure tagged10-Q income statement, on EDGAR
- Net income−$1.3MNo year-earlier figure tagged10-Q income statement, on EDGAR
- Diluted EPS−$5.44No year-earlier figure tagged. Split-adjusted, as the tables show it; the filing reported −$0.3210-Q income statement, on EDGAR
- Cash and cash equivalents$3.7MNo year-earlier figure tagged10-Q balance sheet, on EDGAR
- Cash from operations−$1.3MNo year-earlier figure tagged10-Q cash flow statement, on EDGAR; the filing reports year-to-date cash flows; this quarter is the year-to-date total less the earlier quarters
Similar companies
Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.
- Healthy Extracts HYEX public float $4M, Jun 30, 2025
- Theriva Biologics TOVX public float $4M, Jun 30, 2025
- Jaguar Health JAGX public float $4M, Jun 30, 2025
- China Pharma Holdings CPHI public float $4M, Jun 30, 2025
- Synlogic SYBX public float $4M, Jun 30, 2025
